6,7-Dimethoxy-3-(3-methoxyphenyl)isoquinolin-1-amine induces mitotic arrest and apoptotic cell death through the activation of spindle assembly checkpoint in human cervical cancer cells

Carcinogenesis. 2013 Aug;34(8):1852-60. doi: 10.1093/carcin/bgt133. Epub 2013 Apr 24.

Abstract

Previously, we reported that 6,7-dimethoxy-3-(3-methoxyphenyl)isoquinolin-1-amine (CWJ-082) has potent cytotoxic effects on various cancer cells, but the underlying molecular mechanism responsible was not determined. In the present study, CWJ-082 caused cervical cancer cell cycle arrest at the G2/M phase and subsequent caspase-dependent apoptosis. The mitotic arrest caused by CWJ-082 found to be due to increases in the activation of cyclin-dependent kinase 1/cyclin B1 complex and the phosphorylation of histone H3. In addition, CWJ-082 induced the phosphorylation of BubR1 and the association between mitotic arrest deficient 2 (Mad2) and cell division cycle protein 20. These findings suggested that CWJ-082 activated the mitotic spindle checkpoint. Furthermore, knockdown of the spindle checkpoint proteins BubR1 or Mad2 using specific small interfering RNAs significantly reduced CWJ-082-induced mitotic cell accumulation and apoptosis. In addition, CWJ-082 induced the appearance of spindle abnormalities by inducing α-tubulin polymerization. In BALB/c(nu/nu) mice bearing a HeLa xenograft, CWJ-082 significantly inhibited tumor growth. Taken together, these results suggest that CWJ-082 inhibits cell growth via mitotic arrest by activating the mitotic spindle checkpoint and by inducing α-tubulin polymerization and that these events ultimately lead to the apoptosis of human cervical cancer cells and inhibit tumor growth in HeLa xenograft mice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Apoptosis / drug effects*
  • Apoptosis / genetics
  • CDC2 Protein Kinase / genetics
  • CDC2 Protein Kinase / metabolism
  • Caspases / genetics
  • Caspases / metabolism
  • Cdc20 Proteins / genetics
  • Cdc20 Proteins / metabolism
  • Cell Cycle Checkpoints / drug effects*
  • Cell Cycle Checkpoints / genetics
  • Cell Division / drug effects
  • Cell Division / genetics
  • Cell Line, Tumor
  • Cyclin B1 / genetics
  • Cyclin B1 / metabolism
  • Female
  • G2 Phase / drug effects
  • G2 Phase / genetics
  • HeLa Cells
  • Histones / genetics
  • Histones / metabolism
  • Humans
  • Isoquinolines / pharmacology*
  • M Phase Cell Cycle Checkpoints / drug effects*
  • M Phase Cell Cycle Checkpoints / genetics
  • Mad2 Proteins / genetics
  • Mad2 Proteins / metabolism
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Microtubules / genetics
  • Microtubules / metabolism
  • Mitosis / drug effects*
  • Mitosis / genetics
  • Phosphorylation / drug effects
  • Phosphorylation / genetics
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism
  • Tubulin / genetics
  • Tubulin / metabolism
  • Uterine Cervical Neoplasms / genetics*
  • Uterine Cervical Neoplasms / metabolism
  • Uterine Cervical Neoplasms / pathology

Substances

  • Antineoplastic Agents
  • CCNB1 protein, human
  • Cdc20 Proteins
  • Cyclin B1
  • Histones
  • Isoquinolines
  • MAD2L1 protein, human
  • Mad2 Proteins
  • Tubulin
  • CDC20 protein, human
  • BUB1 protein, human
  • Protein Serine-Threonine Kinases
  • CDC2 Protein Kinase
  • Caspases